26 Programs

  • Novel Investigational Antibody-Drug Conjugates for Ovarian Cancer

    Explore program
    • February 2026 1.25 ABIM MOC, ABS MOC, CME 54min
      • K
      Kathleen N Moore
    • February 2026 0.75 ABIM MOC, ABS MOC, CME 36min
      • K
      Kathleen N Moore
  • The New Understanding of Toxicities Associated with Chimeric Antigen Receptor (CAR) T-Cell Therapy

    Explore program
    • December 2025 1.25 ABIM MOC, CME 52min
      • M
        Matthew Lunning, MD
      Matthew Lunning
    • December 2025 0.75 ABIM MOC, CME 34min
      • M
        Matthew Lunning, MD
      Matthew Lunning
  • Current and Future Management of HER2-Altered Non-Small Cell Lung Cancer

    Explore program
    • November 2025 1.25 ABIM MOC, ABS MOC, CME 1h 5min
      • J
      John V Heymach
    • November 2025 0.75 ABIM MOC, ABS MOC, CME 26min
      • J
      John V Heymach
  • The Role of Oral Selective Estrogen Receptor Degraders in the Management of ER-Positive Metastatic Breast Cancer

    Explore program
    • October 2025 1 ABIM MOC, ABS MOC, CME 41min
      • P
      Patrick Neven
    • October 2025 1 ABIM MOC, ABS MOC, CME 42min
      • P
      Patrick Neven